Global Immune Repertoire Sequencing Market Size, Trends & Growth Opportunity, By Product Type, By Application, By End User, By Region and Forecast till 2027

Global Immune Repertoire Sequencing Market Size, Trends & Growth Opportunity, By Product Type (assay kits (TCR kits, and BCR Kits), and Instrument (NGS, and PCR)), By Application (Biomarker Discovery, Cancer Immunotherapy, Vaccine Development & Efficacy, Transplant Rejection &Tolerance, Infectious Diseases and Other), By End User, By Region and Forecast till 2027.

Global Immune Repertoire Sequencing Market

The Global Immune Repertoire Sequencing Market was valued at USD 116.2 million in 2020 and is expected to reach 180 million by 2027 at a CAGR of 7.6% 2020-2027.

The Immune Repertoire Sequencing is defined as a rate and sensitive platform technology with less fitfall. It is used in biomarker discovery to improve the success rate & cost effectiveness of rational drug development. Also, they are used in the variety of applications such as cancer immunotherapy, asthma & allergies, infectious diseases research and many more.

Market Drivers

The increase in research and development and demand for genomic & repertoire sequencing-based research is anticipated to boost the growth of global immune repertoire sequencing market growth over the forecast period. Also, the increase in launches of novel products by key players is expected to drive the market growth. For instance, in 2016, ArcherDX, Inc. had expanded its product portfolio with the launch of its new Archer Immunoverse immune repertoire sequencing assays at the American Society of Hematology.

Furthermore, the increase in demand for personalized medicine will positively influence the growth of the global immune repertoire sequencing market. Moreover, growing the role of next-generation immune repertoire sequencing for personalized immune modulation is expected to support the global immune repertoire sequencing market growth.

Market Restraints

Various challenging factors in global immune repertoire sequencing market include distinguishing biological variations from the errors & the bias introduced in different steps. Conventional & novel bioinformatics techniques like Haystack Heuristic, high throughput screening, and others are not up to the mark due to unsatisfactory scalability & sensitivity as well as limitation in providing sufficient & accurate data which are expected to hamper the global immune repertoire sequencing market growth.

Market Segmentation

The Global Immune Repertoire Sequencing Market is segmented into product type such as assay kits (TCR kits, and BCR Kits), and Instrument (NGS, and PCR), by application such as Biomarker Discovery, Cancer Immunotherapy, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection &Tolerance, Infectious Diseases and Other. Further, market is segmented into end users such as Biotechnology and Pharmaceuticals Companies, Diagnostics Labs, Academic and Research Institutes and Others.

Regional Analysis

The Global Immune Repertoire Sequencing Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America region is expected to held a dominant position in the overall immune repertoire sequencing market over the forecast period, due to the high presence of key industry players in this region. Further, Europe region is expected to gain momentum over the forecast period, due to the increase in funding by the government bodies to support international innovative projects & marketable innovative products, processes, and services, in order to cater unmet medical need.

Market Key Players

Various key players are listed in this report such as Thermo Fisher Scientific, Inc., ArcherDX, Inc., Illumina Inc., Roche Holding AG, CD Genomics, Atreca, Inc., Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., Takara Bio, Inc., etc.

Market Taxonomy

By Product Type

• Assay Kits
• TCR kits
• BCR Kits
• Instrument
• NGS
• PCR

By Application

• Biomarker Discovery
• Cancer Immunotherapy
• Autoimmune Diseases
• Vaccine Development and Efficacy
• Transplant Rejection &Tolerance
• Infectious Diseases
• Other

By End User

• Biotechnology and Pharmaceuticals Companies
• Diagnostics Labs
• Academic and Research Institutes
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report

• What are the Key Opportunities in Global Immune Repertoire Sequencing Market?
• What will be the growth rate from 2019 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?